iPath Pure Beta Lead ETN
LEDD
LEDD was delisted on the 11th of April, 2018.
1 hedge funds and large institutions have $54K invested in iPath Pure Beta Lead ETN in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
17% more capital invested
Capital invested by funds: $46K → $54K (+$8K)
0% more funds holding
Funds holding: 1 → 1 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$64 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $54K | -$64 | -2 | -0.1% |
|
LEDD Hedge Fund Activity: Q3 2016 in Review
1 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Lead ETN (LEDD) for Q3 2016, worth a combined $54K — up 17% from $46K a quarter earlier.
Fund positioning in LEDD was balanced in Q3 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $64.
- 1 institutional investor held iPath Pure Beta Lead ETN (LEDD) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $54K of iPath Pure Beta Lead ETN stock for Q3 2016, up 17% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta Lead ETN positions in Q3 2016 and 0 closed out.
- The largest iPath Pure Beta Lead ETN seller in Q3 2016 was UBS Group, an estimated $64 sold.
Based on aggregated 13F filings for Q3 2016.